Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GRCE)

Q: What does CUSIP 00439U104 represent in this 13F holders report?

CUSIP 00439U104 is the security identifier for GRCE - Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held GRCE - Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q2 2026?

33 institutional investors reported GRCE - Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 00439U104

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 3,849,792
Total 13F value: $8,738,412
Share change: -418,080
Put/Call ratio: 0%
SEC-reported price per share: $2.27
Number of holders: 33
Value change: -$4,035,492
Number of buys: 21
Number of sells: 15
Shares outstanding: 18,244,606

Security key

00439U104

Report period

Q2 2026

Institutions

Top holders

GRCE full security history Ownership snapshot Full 13F holder table Previous quarter: Q4 2025 Grace Therapeutics, Inc. SEC filings Grace Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 00439U104

Previous quarter: Q4 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of GRCE - Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ADAR1 Capital Management,...

Disclosed value leader

ADAR1 Capital Management,...

Comparable rows

15/15

Latest evidence

30 Jun 2026

13D/G 3/4/5 13F Lead comparable stake: 9.9% 13D/G row: ADAR1 Capital Management, LLC Showing 1-6 of 15 holder rows.

Quick read

ADAR1 Capital Management, LLC leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ADAR1 Capital Management, LLC's linked filing trail.

Comparable ownership Top 5

ADAR1 Capital Management, LLC 9.9%

Nantahala Capital Management, LLC 6.8%

Orin Hirschman 4.9%

Cerity Partners LLC 4.7%

Eversept Partners, LP 4.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ADAR1 Capital Management, LLC	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	9.9%	$4,100,110 1,806,216 shares	+$201,553	30 Jun 2026
Nantahala Capital Management, LLC	13F 13D/G Company 13F 13D/G	6.8% from 13D/G	$3,371,580 728,203 shares	—	31 Mar 2026
Orin Hirschman	13D/G 13D/G	4.9%	— 814,000 shares	$0	31 Mar 2026
Cerity Partners LLC	13F Company 13F	4.7%	$3,931,125 849,055 shares	—	31 Mar 2026
Eversept Partners, LP	13F Company 13F	4.1%	$3,503,058 756,600 shares	—	31 Mar 2026
BANK OF AMERICA CORP /DE/	13F Company 13F	2.7%	$2,290,568 494,723 shares	—	31 Mar 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,849,792

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q2 2026 holders

Holder diff

Investor	Q4 2025 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q4 2025 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend